Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prodromal Alzheimer's Disease”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Early research (Phase 1)Study completedNCT02640092
What this trial is testing

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 72
Not applicableEnded earlyNCT04846426
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 67
Early research (Phase 1)Study completedNCT04566003
What this trial is testing

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Genentech, Inc. 40
Not applicableUnknownNCT05468268
What this trial is testing

Noninvasive Brain Stimulation for pAD

Who this might be right for
Alzheimer's Disease - MCI
Università degli Studi di Trento 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06182085
What this trial is testing

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
PRInnovation GmbH 304
Large-scale testing (Phase 3)Ended earlyNCT03444870
What this trial is testing

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 1,053
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06957418
What this trial is testing

Alzheimer's Tau Platform: Master Protocol

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer DiseaseProdromal Alzheimer's Disease
Paul S. Aisen 750
Testing effectiveness (Phase 2)Looking for participantsNCT05462106
What this trial is testing

Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Who this might be right for
Amyloid PlaqueBeta-AmyloidDSAD+2 more
AC Immune SA 176
Not applicableLooking for participantsNCT05934188
What this trial is testing

Exploring the Gut-Brain Axis in Ageing and Neurodegeneration

Who this might be right for
HealthyProdromal Alzheimer's DiseaseParkinson Disease+1 more
IRCCS San Camillo, Venezia, Italy 200
Not applicableStudy completedNCT03834402
What this trial is testing

INTERCEPTOR Project: From MCI to Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Catholic University of the Sacred Heart 500
Large-scale testing (Phase 3)Ended earlyNCT02670083
What this trial is testing

A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 813
Testing effectiveness (Phase 2)Ended earlyNCT04592341
What this trial is testing

Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 192
Large-scale testing (Phase 3)Ended earlyNCT03114657
What this trial is testing

Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 806
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192913
What this trial is testing

Glymphatic Function TMS Study

Who this might be right for
Mild Cognitive Impairment
University of Arizona 20
Not applicableUnknownNCT03138018
What this trial is testing

Aging Stereotypes and Prodromal Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)
Assistance Publique Hopitaux De Marseille 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07167966
What this trial is testing

Alzheimer's Tau Platform: Regimen A - AADvac1

Who this might be right for
Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease
Paul S. Aisen 375
Not applicableStudy completedNCT01231295
What this trial is testing

Isotopic Imaging for Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nīmes 143
Not applicableStudy completedNCT03249688
What this trial is testing

Multimodal Preventive Trial for Alzheimer's Disease

Who this might be right for
Alzheimer Disease; Prodromal
Karolinska Institutet 93
Not applicableStudy completedNCT04733989
What this trial is testing

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease, Early OnsetMild Cognitive Impairment+3 more
GAP Innovations, PBC 1,002
Testing effectiveness (Phase 2)Ended earlyNCT03289143
What this trial is testing

Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 457
Load More Results